DRKS00034678招募中不适用
IOL comparison study with the RALV device - RALV_IOL-Study
ACMIT Gmbh0 个研究点目标入组 30 人开始时间: 2024年7月15日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 40 Years（—）
- 性别
- All
入选标准
- •Refraction: Sphere (Sph): between -3 dpt and +3 dpt
- •Refraction: Cylinder (Cyl): <= 1 dpt
- •Visual acuity >= 1 decimal (or <= 0 logMAR)
- •After the medical examination, the subject was found suitable to receive cyclopentolate eye drops.
- •Informed and signed consent to participate in the study
排除标准
- •Diseases that affect visual acuity (glaucoma, cataract, AMD, corneal opacity or other retinal diseases)
- •Irregular astigmatism
- •Previous eye surgery of any kind
- •In women: pregnancy or breastfeeding
研究者
相似试验
已完成
不适用
Pilot Study of a Raltegravir Based NRTI Sparing RegimenAcquired Immune Deficiency SyndromeAIDSHuman Immunodeficiency VirusHIV InfectionsNCT00814879Yale University60
Unknown
4 期
RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected PatientsChronic Infection With HIVNCT01829802Pedro Cahn50
已完成
不适用
A Novel Assay for Predicting Surgical Outcomes in Pelvic Organ ProlapseProlapse GenitalNCT03534830University of South Florida51
Unknown
不适用
Safety, Tolerability and Efficacy of HAVAI, for Correction of Inter-metatarsal AngleHallux ValgusNCT02831868Rabin Medical Center30
Unknown
不适用
Raltegravir-based Antiretroviral Therapy for Resistant HIV-1 InfectionAIDS/HIV PROBLEMNCT01844310Peking Union Medical College300